Akero Therapeutics Vs. 89bio Industry Stock Comparison

Buy

63

AKRO
Akero Therapeutics

Last Price:

30.93

Seasonality Move:

8.52%

Sell

36

ETNB
89bio

Last Price:

8.30

Seasonality Move:

5.01%

Buy

63

Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

The current Akero Therapeutics [AKRO] share price is $30.92. The Score for AKRO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

36

89bio (ETNB) is a Sell

Is 89bio a Buy, Sell or Hold?

The current 89bio [ETNB] share price is $8.30. The Score for ETNB is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
ETNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

The Akero Therapeutics share price today is $30.92
The current trend is moderately bearish and AKRO is experiencing slight buying pressure.

ETNB Stock Price Chart

What is 89bio's stock price today?

The 89bio share price today is $8.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ETNB is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.21	Buy
Relative Strength Index (14 RSI):	48.79	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(30.15 - 33.33)	Sell
Bollinger Bands (100):	(25.8 - 31)	Buy

ETNB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.08	Buy
Relative Strength Index (14 RSI):	45.38	Sell
Chaikin Money Flow:	-579850	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.16 - 9.62)	Sell
Bollinger Bands (100):	(7.72 - 9.14)	Sell

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	31.7	Sell
20-day SMA:	31.74	Sell
50-day SMA:	30.46	Buy
200-day SMA:	25.73	Buy
8-day EMA:	31.38	Sell
20-day EMA:	31.33	Sell
50-day EMA:	30.33	Buy
200-day EMA:	27.58	Buy

ETNB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8.9	Sell
20-day SMA:	8.94	Sell
50-day SMA:	8.29	Buy
200-day SMA:	9.06	Sell
8-day EMA:	8.77	Sell
20-day EMA:	8.74	Sell
50-day EMA:	8.55	Sell
200-day EMA:	9.09	Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

89bio Earnings Growth & ETNB Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.96 per share, and an increase next year of $0.11 per share.

Akero Therapeutics Technical Analysis

	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3	Dec 4
	Nov								Dec
	20	21	22	25	26	27	29	02	03	04
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

89bio Technical Analysis

	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3	Dec 4
	Nov								Dec
	20	21	22	25	26	27	29	02	03	04
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):